Reaction

Catheter Site Induration reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 152 reports · 2 co-occurring drugs

As of the last recalculation, Catheter Site Induration appears in 152 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 148.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Epoprostenol13148.6148.8
Rasagiline Mesylate563.663.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.